Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Remcyta 500mg Injection

Prescription Icon
Prescription Required

Marketer

Alkem Laboratories Ltd

Salt Composition

Cytarabine (500mg)

Overview Remcyta 500mg Injection

Cytarab 500mg injection combats specific hematological malignancies. Its use may extend to other conditions as directed by a physician, potentially within a combined chemotherapy regimen. Administered intravenously or subcutaneously by a healthcare provider, the dosage and frequency are individualized, adapting to treatment response and evolving needs. Strict adherence to the prescribed regimen is crucial; deviations can induce severe adverse effects. Therapeutic benefits might not be apparent immediately; discontinuation should only occur with physician approval. Common side effects encompass skin reactions (rash, ulceration), nausea, vomiting, and alopecia. A reduction in blood cell counts, increasing infection and bleeding risks, is possible. Report chills, unusual hemorrhaging, dark stools, or bruising to your doctor. Regular blood tests monitoring blood cell counts, cardiac, hepatic, and uric acid levels are mandatory. Prior to commencing treatment, disclose any bleeding disorders, liver or kidney impairment, or concurrent use of antimicrobial agents. Potential drug interactions necessitate a comprehensive medication review with your physician. This medication is contraindicated during pregnancy and lactation; effective contraception for both partners is essential throughout treatment.

Uses of Remcyta 500mg Injection

Hematologic malignancy

Major Benefits of Remcyta 500mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

Common Side effects of Remcyta 500mg Injection:

  • Rash
  • Skin ulcer
  • Nausea
  • Vomiting
  • Hair loss
  • Abdominal pain
  • Anal ulcers
  • Anemia (low number of red blood cells)
  • Decreased white blood cell count
  • Fever
  • Infection
  • Abnormal liver function
  • Low blood platelets
  • Mouth ulcer
  • Pneumonia
  • Sepsis
  • Mouth sore
  • Stomatitis (Inflammation of the mouth)

How to use Remcyta 500mg Injection:

The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

How Remcyta 500mg Injection works:

Remcyta 500mg Injection halts cancer cell proliferation by disrupting DNA and RNA synthesis through the replacement of essential components. This action effectively inhibits the growth and reproduction of cancerous cells.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

The safety of combining Remcyta 500mg Injection with alcohol is undetermined. Seek medical advice before doing so.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Remcyta 500mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. Nevertheless, in exceptional, life-threatening circumstances, a physician might deem its use justifiable if the potential advantages outweigh the inherent dangers. Physician consultation is mandatory.

Breast feedingBreast feedingUNSAFE

Administering Remcyta 500mg Injection while breastfeeding poses a significant risk. Evidence indicates potential harm to the infant from the medication.

DrivingDrivingUNSAFE

Administering Remcyta 500mg Injection may induce adverse reactions that could impair driving capabilities.

KidneyKidneySAFE IF PRESCRIBED

Remcyta 500mg Injection can be administered to patients with kidney conditions without altering the dosage. Nevertheless, consultation with a physician is advisable if renal impairment is present.

LiverLiverCONSULT YOUR DOCTOR

Data regarding Remcyta 500mg Injection's use in individuals with hepatic impairment is scarce. Physician consultation is advised. Given this limited data, prudent administration of Remcyta 500mg Injection is suggested for patients exhibiting liver dysfunction.

What if you forget to take Remcyta 500mg Injection :

NA

Facts to Know About Remcyta 500mg Injection

LabelValue
Type of Compound Synthetic pyrimidine base analog
Addictive None.
Medication Classification Cancer therapeutics
Mechanism of Action Metabolic inhibitors

FAQs on Remcyta 500mg Injection

Remcyta 500mg Injection is a non-vesicant; however, cautious handling is recommended.
Remcyta 500mg Injection has not been associated with ototoxicity. Nevertheless, seek medical advice should this adverse reaction occur.
Indeed, Remcyta 500mg Injection is a chemotherapy agent.
Hair loss is a possible side effect of Remcyta 500mg Injection.
Remcyta 500mg Injection blocks DNA reproduction by halting DNA synthesis.
Remcyta 500mg Injection
444
MRP 541
17% off